
Meet us at Optometridagarna
We are in Gothenburg on 19 and 20 September. Come by and see how it works, inside the routine eye exam.
About the fair (opens in a new tab)In Swedish
News
Press coverage, research and the steps along the way, from the clinic at St. Erik Eye Hospital to the routine eye exam. Newest first.

We are in Gothenburg on 19 and 20 September. Come by and see how it works, inside the routine eye exam.
About the fair (opens in a new tab)In Swedish

We are in Gothenburg on 19 and 20 September. Come by and see how it works, inside the routine eye exam.
About the fair (opens in a new tab)In Swedish

Karolinska Institutet Innovation on its incubator company's first round, with Norrsken Launcher as lead investor and the capital going toward regulatory approval and the next steps of the product.
Breakit on why Norrsken backs Eyedentity in its AI for good category, and on a cancer where survival has not improved in fifty years.
Read the article (opens in a new tab)In Swedish
The decision support now runs in selected Synologen practices, in routine patient care.
SVT reports from St. Erik Eye Hospital on the research behind Eyedentity, with Gustav Stålhammar on the ambition to find aggressive eye cancer earlier, at the routine visit.
Watch the feature (opens in a new tab)In Swedish

Compares the model's score from one fundus photograph with MOLES as scored by specialists with additional imaging, in 86 small pigmented choroidal lesions.

Gustav Stålhammar spoke about decision support for early detection at the optical trade fair in Stockholm.

ScholarGPS ranks our Chief Scientific Officer fourth globally in his research field over the past five years.

Swedish opticians and optometrists triaged 25 small pigmented lesions with the MOLES system; the study then compares their referrals with the model's threshold on the same images.
Retrospective multicentre study on 802 fundus photographs from 688 patients, with the model trained, validated and then tested on independent image sets.